2013 American Transplant Congress
Prevalence of Metabolic Syndrome in Renal Transplant Patients: Comparison of Two Diagnostic Criteria
Renal Transplantation Service, Hospital das Clinicas - FMUSP, Sao Paulo, Brazil
Metabolic syndrome (MS) is now recognized as a risk factor for cardiovascular disease (CV), the leading cause of death with a functioning graft in renal…2013 American Transplant Congress
Transitions of Care To Reduce Early Readmissions Following Kidney Transplantation
Pharmacy, University of Michigan Health System, Ann Arbor, MI
Background: Hospital readmission became an important metric for measuring quality of patient care. Although transitions of care interventions prevented readmission in various settings, they have…2013 American Transplant Congress
Threatened Kidney Allograft: Use of mTOR- Inhibitor Increases All Cause Mortality
Nephrology, UMMC, Baltimore, MD
Background:Acute allograft dysfunction due to IFTA is often attributed to cumulative exposure to tacrolimus. Can replacement of CNI with m-TOR inhibitor prevent progression in IF/TA…2013 American Transplant Congress
Increasing Living Donor (LD) Kidney Transplants by Streamlining the Evaluation Process
UNC Center for Transplant Care, Chapel Hill; UNC Department of Surgery, Chapel Hill
While the organ waiting list in the US keeps growing, number of donors stays the same increasing the gap between recipients and donors. One of…2013 American Transplant Congress
Levothyroxine Therapy Prior to Brain Death Declaration Increases the Number of Solid Organ Donations
Department of Surgery, The University of Arizona, Tucson, AZ
INTRODUCTION: Protocols call for the start of hormonal therapy with Levothyroxine after declaration of brain death. As the hormonal perturbations occur during the process of…2013 American Transplant Congress
New Onset Proteinuria after Conversion to Sirolimus in Renal Transplantation
To avoid nephrotoxicity calcineurin inhibitors are frequently replaced by mTOR-inhibitors like Sirolimus (SRL). Worsening of proteinuria has been reported after conversion to mTOR-inhibitors. We aimed…2013 American Transplant Congress
Nonadherence Related to Psychosocial Issues Predominates in the Majority of Acute Rejections during Early Posttransplant Period
Kidney Transplantation, St. Vincent Hospital, Indianapolis, IN
BACKGROUND: Nonadherence (NA) is a known cause of acute rejection (AR) and graft loss in this modern era of immunosuppression. However, extent of contribution of…2013 American Transplant Congress
Sarcopenia of Cirrhosis Does Not Reverse after Liver Transplantation
Sarcopenia (loss of muscle mass) is common in patients with end stage liver disease (ESLD). Sarcopenia is potentially reversible after liver transplantation (LT) but no…2013 American Transplant Congress
Persistent Asymptomatic C4d Staining in the First-Year after Heart Transplantation Is a Marker for Cardiac Allograft Vasculopathy
Cedars-Sinai Heart Institute, Los Angeles, CA
BACKGROUND: Antibody-mediated rejection (AMR) after heart transplantation has recently been defined as a pathological diagnosis. This would include immunopathology which includes C4d staining and histologic…2013 American Transplant Congress
Residual Renal Function in Living Kidney Donors: Does Remaining Kidney Volume Matter?
Ohio State University, Columbus; IUH Transplant, Indiana University Health, Indianapolis
Background:It is generally accepted that in living kidney donor nephrectomy for transplantation, the donor should remain with the larger kidney volume if possible. It has…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 178
- Next Page »